SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Mika K. Kaneko, Hiroharu Oki, Satoshi Ogasawara, Michiaki Takagi, Yukinari Kato, Anti-podoplanin Monoclonal Antibody LpMab-7 Detects Metastatic Lesions of Osteosarcoma, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, 2015, 34, 3, 154

    CrossRef

  2. 2
    Hiroharu Oki, Satoshi Ogasawara, Mika Kato Kaneko, Michiaki Takagi, Masanori Yamauchi, Yukinari Kato, Characterization of Monoclonal Antibody LpMab-3 Recognizing Sialylated Glycopeptide of Podoplanin, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, 2015, 34, 1, 44

    CrossRef

  3. 3
    Hiroharu Oki, Mika K. Kaneko, Satoshi Ogasawara, Yuta Tsujimoto, Xing Liu, Masato Sugawara, Yuya Takakubo, Michiaki Takagi, Yukinari Kato, Characterization of Monoclonal Antibody LpMab-7 Recognizing Non-PLAG Domain of Podoplanin, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, 2015, 34, 3, 174

    CrossRef

  4. 4
    V. Lorenz, D. Stegner, S. Stritt, T. Vogtle, F. Kiefer, W. Witke, J. Schymeinsky, S. P. Watson, B. Walzog, B. Nieswandt, Targeted downregulation of platelet CLEC-2 occurs through Syk-independent internalization, Blood, 2015, 125, 26, 4069

    CrossRef

  5. 5
    Yukinari Kato, Mika Kato Kaneko, A Cancer-specific Monoclonal Antibody Recognizes the Aberrantly Glycosylated Podoplanin, Scientific Reports, 2014, 4,

    CrossRef

  6. 6
    Satoshi Takagi, Tomoko Oh-hara, Shigeo Sato, Bo Gong, Miho Takami, Naoya Fujita, Expression of Aggrus/podoplanin in bladder cancer and its role in pulmonary metastasis, International Journal of Cancer, 2014, 134, 11
  7. 7
    David Stegner, Sebastian Dütting, Bernhard Nieswandt, Mechanistic explanation for platelet contribution to cancer metastasis, Thrombosis Research, 2014, 133, S149

    CrossRef

  8. 8
    Satoshi Takagi, Ai Takemoto, Miho Takami, Tomoko Oh-hara, Naoya Fujita, Platelets promote osteosarcoma cell growth through activation of the platelet-derived growth factor receptor-Akt signaling axis, Cancer Science, 2014, 105, 8
  9. 9
    Qi Dang, Jie Liu, Juan Li, Yuping Sun, Podoplanin: a novel regulator of tumor invasion and metastasis, Medical Oncology, 2014, 31, 9

    CrossRef

  10. 10
    Kenichi Miyata, Satoshi Takagi, Shigeo Sato, Hiroshi Morioka, Kiyotaka Shiba, Tamiko Minamisawa, Miho Takami, Naoya Fujita, Suppression of Aggrus/podoplanin-induced platelet aggregation and pulmonary metastasis by a single-chain antibody variable region fragment, Cancer Medicine, 2014, 3, 6
  11. 11
    Mizue Fujii, Masaru Honma, Hidetoshi Takahashi, Akemi Ishida-Yamamoto, Hajime Iizuka, Intercellular contact augments epidermal growth factor receptor (EGFR) and signal transducer and activator of transcription 3 (STAT3)-activation which increases podoplanin-expression in order to promote squamous cell carcinoma motility, Cellular Signalling, 2013, 25, 4, 760

    CrossRef

  12. 12
    L. Navarro-Núñez, S. A. Langan, G. B. Nash, S. P. Watson, The physiological and pathophysiological roles of platelet CLEC-2, Thrombosis and Haemostasis, 2013, 109, 6, 991

    CrossRef

  13. 13
    Kate L. Lowe, Leyre Navarro-Nunez, Stephen P. Watson, Platelet CLEC-2 and podoplanin in cancer metastasis, Thrombosis Research, 2012, 129, S30

    CrossRef

  14. 14
    Kinta Hatakeyama, Mika Kato Kaneko, Yukinari Kato, Tetsunori Ishikawa, Kensaku Nishihira, Yuta Tsujimoto, Yoshisato Shibata, Yukio Ozaki, Yujiro Asada, Podoplanin expression in advanced atherosclerotic lesions of human aortas, Thrombosis Research, 2012, 129, 4, e70

    CrossRef

  15. 15
    N. Fujita, S. Takagi, The impact of Aggrus/podoplanin on platelet aggregation and tumour metastasis, Journal of Biochemistry, 2012, 152, 5, 407

    CrossRef